Dexcom stock price holding at $123

Dexcom stock price holding at $123.40 shows resilience against broader market volatility. Analysts highlight defensive growth qualities as a hedge within equity portfolios. View original content to download multimedia: https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-dexcom-inc---dxcm-302574431.html U.S. revenues (73% of total revenues) increased 15% on a year-over-year basis to $841 million. International revenues (27%) improved 16% (14% on an organic basis) year over year to $316.1 million. Dexcom stock price edged up to $124.70, partly fueled by broker upgrades citing expanding user base among Type 2 diabetes patients.